1.
Br J Haematol
; 202(6): 1079-1080, 2023 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37519086
2.
Semin Diagn Pathol
; 40(3): 182-186, 2023 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37032284
RESUMO
Therapy-related myeloid neoplasms (t-MN) are a heterogeneous group of aggressive myeloid neoplasms that arise following exposure to various cytotoxic therapeutic agents and/or ionizing radiation for treatment of prior non-myeloid malignancy or autoimmune disease. Each therapeutic group has been associated with varying latency intervals from the time of therapy exposure to onset of t-MN, as well as certain recurrent genetic alterations. This review will focus on the molecular genetic alterations that have been described in t-MNs, as well as recent updates regarding diagnostic classification.
Assuntos
Antineoplásicos , Leucemia Mieloide Aguda , Transtornos Mieloproliferativos , Segunda Neoplasia Primária , Humanos , Gravidez , Feminino , Leucemia Mieloide Aguda/genética , Segunda Neoplasia Primária/genética , Segunda Neoplasia Primária/patologia , Biologia Molecular
3.
Diagn Cytopathol
; 46(7): 636-638, 2018 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29732727